Palopegteriparatide for treating chronic hypoparathyroidism [ID6380]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 16 July 2025
Teprotumumab for treating thyroid eye disease [ID6432]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 20 August 2025